Relationship between cytokines and tumour markers in patients with chronic heart failure

European Journal of Heart Failure

Volumn 8, Issue 3, 2006, Pages 270-274

  Kosar, Feridun ^a   Aksoy, Yuksel ^a   Ozguntekin, Gulacan ^a   Ozerol, Ibrahim ^a   Varol, Ercan ^b  

^a INONU UNIVERSITY   (Turkey)

^b ISPARTA STATE HOSPITAL   (Turkey)

Author keywords

CA 125; Chronic heart failure; Cytokines; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746860611     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.09.002     Document Type: Article

References (36)

1. Mann D.L., and Young J.B. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105 (1994) 897-904
2. Paulus W.J. How are cytokines activated in heart failure?. Eur J Heart Fail 1 (1999) 309-312
3. Blum A., and Miller H. Role of cytokines in heart failure. Am Heart J 135 (1998) 181-186
4. Adamopoulos S., Parissis J.T., and Kremastinos D.T. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 3 (2001) 517-526
5. Feldman A.M., Combes A., Wagner D., et al. The role of tumor necrosis factor in pathophysiology of heart failure. J Am Col Cardiol 35 (2000) 537-544
6. Munger M.A., Johnson B., Amber I.J., Callahan K.S., and Gilbert E.M. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77 (1996) 723-727
7. Kosar F., Varol E., Ileri M., Ayaz S., Hisar I., and Kisacik H. Circulating cytokines and complements in chronic heart failure. Angiology 50 5 (1999) 403-408
8. Levine B., Kalman J., Mayer L., Fillit H., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
9. MacGowan G.A., Mann D.L., Kormos R.L., et al. Circulating interleukin-6 in severe heart failure. Am J Cardiol 79 (1997) 1128-1131
10. Yamaoka M., Yamaguchi S., Okuyama M., and Tomoike H. Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Circ J 63 (1999) 951-956
11. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., and Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
12. Kelly R.A., and Smith T.W. Cytokines and cardiac contractile function. Circulation 95 (1997) 778-781
13. Raymond R.J., Dehmer G.J., Theoharides T., and Deliargyris E.N. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141 (2001) 435-438
14. Shan K., Kurrelmeyer K., Seta Y., et al. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 12 (1997) 218-223
15. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
16. Bast Jr. R.C., Klug T.L., St. John E., et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309 (1983) 883-887
17. Lavin P.T., Knapp R.C., Malkasion G., Whitney C.W., Berek J.C., and Bast Jr. R.C. CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol 69 (1987) 223-227
18. Kenemans P., Yedema C.A., and Bon G.G. CA 125 in gynecological pathology: a review. Eur J Obstet Gynecol Reprod Biol 49 (1993) 115-124
19. Vander Burg M.E., Lammes F.B., and Verwei J.J. CA 125 in ovarian cancer. Neth J Med 40 (1992) 36-51
20. Canney P.A., Moore M., Wilkinson P.M., and James R.D. Ovarian cancer antigen CA 125: a prospective clinical assessment of its role as a tumor marker. Br J Cancer 50 (1984) 765-769
21. Sjovall K., Nilsson B., and Einhorn N. The significance of serum CA 125 elevation malignant and nonmalignant diseases. Gynecol Oncol 85 (2002) 175-178
22. Ozguroglu M., Turna H., Demir G., et al. Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma. Am J Clin Oncol 22 (1999) 615-618
23. Sakamoto K., Haga Y., Yoshimura R., Egami H., Yokoyama Y., and Akagi M. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. Gut 28 (1987) 323-329
24. Klapdor R., Klapdor U., Bahlo M., et al. CA 125 in carcinomas of the digestive tract. Dtsch Med Wochenschr 199 (1984) 1949-1954
25. Talbot R.W., Jacobsen D.J., Nagorney D.M., Malkasian G.D., and Ritts Jr. R.E. Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer. Surg Gynecol Obstet 168 (1989) 407-412
26. Candocia S.A., and Locker G.Y. Elevated serum CA 125 secondary to tuberculous peritonitis. Cancer 72 (1993) 2016-2018
27. Bergmann J.F., Bidart J.M., George M., Beaugrand M., Levy V.G., and Bohuon C. Elevation of CA 125 in patients with benign and malignant ascites. Cancer 59 (1987) 213-217
28. Molina R., Filella X., Bruix J., et al. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37 (1991) 1379-1383
29. Turk H.M., Pekdemir H., Buyukberber S., et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumor Biol 24 (2003) 172-175
30. Kourisa N.T., Zacharosb I.D., Kontogiannia D.D., et al. The significance of CA 125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 7 (2005) 199-203
31. Varol E., Ozaydi{dotless}n M., Dogan A., and Kosar F. Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail 7 5 (2005) 840-843
32. Duman C., Ercan E., Tengiz I., Bozdemir H., Ercan H.E., and Nalbantgil I. Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology 100 1 (2003) 7-10
33. Nagele H., Bahlo M., Klapdor R., Schaeperkoetter D., and Rodiger W. CA 125 and its relation to cardiac function. Am Heart J 137 6 (1999) 1044-1049
34. D'Aloia A., Faggiano P., Aurigemma G., et al. Serum levels of cardohydrate antigen 125 in patients with chronic heart failure. Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities and short term prognosis. J Am Coll Cardiol 41 (2003) 1805-1811
35. Zeimet A.G., Offner F.A., Marth C., et al. Modulation of CA 125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res 17 (1997) 3129-3131
36. Kubonishi I., Bandobashi K., Murata N., et al. High serum levels of CA 125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol 98 2 (1997) 450-452